Welcome to the Second World Congress on Targeting EVs
We are pleased to invite you to the Second World Congress on Targeting EVs, taking place on October 15-16, 2025, in Valencia, Spain. This event will bring together leading international experts to discuss the latest breakthroughs and innovations in extracellular vesicles (EVs).
This conference is the first of its kind to explore the multifaceted roles of extracellular vesicles, with a special focus on mitochondria and microbiota. Join us for cutting-edge discussions and groundbreaking discoveries at the forefront of EV research.
Keynote Speaker 2025 - Prof. Simon Carding:
Extracellular Vesicles as Architects of Systemic Health and Disease
With the unifying theme “Extracellular Vesicles as Architects of Systemic Health and Disease”, Professor Simon Carding’s keynote will serve as a foundational moment for the 2025 edition of the Second World Congress on targeting Extracellular Vesicles. More than an introduction, it is designed to establish a scientific and conceptual framework for the two-day event, one that connects basic biological mechanisms with clinical potential.
Submit your Abstract & Innovation
- Short Oral Submission: September 26
- Poster Submission: October 1
Targeting EVs 2025 First Speakers
Extracellular Vesicles in 2025: Shaping the Medicine of Tomorrow
Consuelo Borrás, University of Valencia, Spain
Microbiota-Derived OMVs: A Novel Mechanism in Brain Function and Alzheimer’s Disease
Roosmarijn E Vandenbroucke, Ghent University, Belgium
Commensal gut bacteria-derived microvesicles: Mediators of microbe-host crosstalk and vehicles for mucosal drug delivery
Simon Carding, Quadram Institute Bioscience, United Kingdom
Microbiota Extracellular Vesicles as a Postbiotic Strategy: Recent Findings and Perspectives
Laura Baldomà, Universitat de Barcelona, Spain
Bacterial Extracellular Vesicles Halt the Progression of Parkinson’s Disease in the Gut
Sandra Morais Cardoso, University of Coimbra, Portugal
Impact of Maternal Extracellular on Embryo Metabolism: Recent Advances and Perspectives
Felipe Vilella, INCLIVA Health Research Institute, Spain
Extracellular Vesicles and Mitochondrial Transfer: A Novel Approach for Treating Parkinson’s Disease
Amalia Dolga, University of Groningen, The Netherlands
The Microbiome’s Secret Handshake: How bacterial EVs hijack immunity and harm the liver in IBD
Claudia Günther, Universitätsklinikum Erlangen, Germany
Mitochondrial Stress Drives Nucleophagy and the Release of Extracellular Vesicles Carrying DAMPs
Carla Lopes, University of Coimbra, Portugal
Inverse Association Between Parkinson’s Disease and Cancer: Could Exosomes Be the Missing Link?
Magdalena Gorska-Ponikowska, Medical University of Gdańsk, Poland
Extracellular Vesicles and Mitochondrial Dynamics: Implications in Aging and Pathology
Maria Cavinato, University of Innsbruck, Austria
Extracellular Vesicles for Treating Lysosomal Storage Disorders
Ibane Abasolo, Instituto de Química Avanzanda de Cataluña – CSIC, Spain
Redox Modulation in Aging Mediated by Stem Cell-derived Extracellular Vesicles
Cristina Mas-Bargues, University of Valencia, Spain
Dietary-Derived Exosome-like Nanoparticles: Advances and Perspectives
Carla Soler, University of Valencia, Spain
Histones as Exosome Membrane Proteins: Their Location and Regulation In Response to Cellular and Mitochondrial
Jonathan Gilthorpe, Umeå University, Sweden
Extracellular Vesicles in Cardio-Metabolic Therapy: Targeting Hypothalamic NLRP3 to Prevent Obesity-Linked Arrhythmias
Ramaroson Andriantsitohaina, University of Montpellier, France
Engineered Extracellualr Vesicles for Regeneration and Rejuvenation: Advances and Perspectives
Lino Ferreira, Faculdade de Medicina da Universidade de Coimbra and associate laboratory CIBB, Portugal
Extracellular Vesicles, Oxidative Stress and Mitochondria: Impact on Retinal Diseases
Francisco J. Romero, Hospital General de Requena, Spain
Targeting EVs 2024 Highlights
The First World Conference Targeting EVs, held on October 17-18, 2024, at the Corinthia Palace in Malta, was a remarkable success. Attendees from over 27 countries gathered to share insights, with more than 40 communications delivered.
📸 Pictures from Targeting EVs 2024 are now available! View them here.
Extracellular Vesicles: Tiny Messengers Poised to Transform Medicine
Webinar: How to Isolate and Characterize Extracellular Vesicles Containing Mitochondrial Material
Abstracts Book and VOD of Targeting EVs 2024
Prof. Andriantsitohaina Wins Best Scientific Contribution 2024 for Nanotechnology Approach Using EVs to Target Obesity Regulation
Mechanistic Insights into Extracellular Vesicles in Skin Aging and Disease – Best Short Oral 2024
The Microbiome Revolution: Personalized Therapies for Tomorrow
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
Microbiota-Derived Extracellular Vesicles as a Postbiotic Strategy to Combat Rotavirus in Neonatal Rats
Tiny Messengers, Big Impact Exosomes as Gatekeepers of Mitochondrial Function
Exploring the Therapeutic Promise of Extracellular Vesicles in Inflammatory Bowel Disease
Abstracts Book and VOD of Targeting EVs 2024
If you were not able to attend the congress online or in-person, the abstracts book and Video of All Presentations of Targeting EVs 2024 are now available for purchase.
The edition of Targeting EVs digital abstracts book compiles 40+ abstracts: from major talks to short oral and poster presentations. It also includes speaker details and emails for direct connections.
Who's attending the Targeting EVs 2025 ?
Analytomix LLC, USA
Ankara University, Turkey
Phileo by Lesaffre, France
Probiotical Research Srl, Italy
Centro Superior de Investigaciones Científicas (CSIC), Spain
Conselleria de Sanitat, Spain
FISABIO – Public Health, Spain
FUNDACIÓN INCLIVA / INCLIVA Health Research Institute, Spain
Ghent University, Belgium
INSERM, France
Institute of Radiation Oncology, Austria
Lithuanian University of Health Sciences (LSMU), Lithuania
Medical University of Gdańsk, Poland
Polish Academy of Sciences, Poland
Nara Institute of Science and Technology (NAIST), Japan
Quadram Institute Bioscience, United Kingdom
Tirol Kliniken, Austria
Tianyu, Taiwan
Umeå University, Sweden
Universidad de los Andes, Chile
Universitätsklinikum Erlangen, Germany
Universitat de Barcelona / University of Barcelona, Spain
University of Coimbra, Portugal
University of Groningen, The Netherlands
University of Innsbruck, Austria
University of Montpellier, France
University of Oulu, Finland
University of Rijeka, Croatia
University of Sevilla, Spain
University of Valencia / Universitat de València, Spain
University of Zurich, Switzerland
University Hospital Zurich, Switzerland
Vita Motus AG, Switzerland
Vrije Universiteit Brussel (VUB), Belgium